Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-92.98%
0%
-92.98%
6 Months
-89.25%
0%
-89.25%
1 Year
-95.35%
0%
-95.35%
2 Years
-99.17%
0%
-99.17%
3 Years
-97.6%
0%
-97.6%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
SOL Global Investments Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-217.71%
EBIT Growth (5y)
-168.74%
EBIT to Interest (avg)
43.45
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
-2.56
Tax Ratio
33.29%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
26.20%
ROE (avg)
31.15%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.13
EV to EBIT
-0.09
EV to EBITDA
-0.09
EV to Capital Employed
1.15
EV to Sales
-0.20
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-1342.02%
ROE (Latest)
-2552.64%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Dec 2023
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.0%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - May'25 - QoQ
May'25
Nov'24
Change(%)
Net Sales
-1.30
-16.10
91.93%
Operating Profit (PBDIT) excl Other Income
-3.00
-18.10
83.43%
Interest
0.20
3.70
-94.59%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-3.10
-48.80
93.65%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
Not Applicable: The company has declared_date for only one period
Consolidated Net Profit
Not Applicable: The company has declared_date for only one period
Annual Results Snapshot (Consolidated) - Nov'24
Nov'24
Nov'23
Change(%)
Net Sales
-2.30
-8.90
74.16%
Operating Profit (PBDIT) excl Other Income
-42.40
-41.60
-1.92%
Interest
9.00
7.30
23.29%
Exceptional Items
0.00
-0.30
100.00%
Consolidate Net Profit
-51.60
-34.10
-51.32%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
YoY Growth in year ended Nov 2024 is 74.16% vs 71.57% in Nov 2023
Consolidated Net Profit
YoY Growth in year ended Nov 2024 is -51.32% vs 88.52% in Nov 2023
About SOL Global Investments Corp. 
SOL Global Investments Corp.
Miscellaneous
SOL Global Investments Corp, formerly Scythian Biosciences Corp, is a Canada-based investment company. The Company is focused on offering strategic investments and partnerships across cultivation, distribution and retail complement the Company’s research and development (R&D) program with the University of Miami. It is engaged in the process of developing drug therapies. The Company conducts a project regarding development of a cannabinoid-based combination drug therapy for the treatment of concussions and traumatic brain injury. The Company also provides a research in area of treatment of gastro-inflammatory disease.
Company Coordinates 
Company Details
100 King Street West, Suite 5600 , TORONTO CA : M5X 1C9
Registrar Details






